These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16968484)

  • 1. Revival of effective and safe high-dose mizoribine for the kidney transplantation.
    Sugitani A; Kitada H; Ota M; Yoshida J; Doi A; Hirakata H; Tanaka M
    Clin Transplant; 2006; 20(5):590-5. PubMed ID: 16968484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
    Takahara S; Takahashi K; Akiyama T; Uchida K; Tanabe K; Amada N; Toma H
    Clin Exp Nephrol; 2013 Dec; 17(6):899-904. PubMed ID: 23430390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
    Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
    Xing S; Yang J; Zhang X; Zhou P
    Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose steroid maintenance for renal transplant recipients.
    Kishikawa H; Nishimura K; Soda T; Yamanaka K; Hirai T; Kyo M; Takeda M; Fujisawa M; Kokado Y; Ichikawa Y
    Transplant Proc; 2010 Dec; 42(10):4030-2. PubMed ID: 21168618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Replacement of mycophenolate mofetil with azathioprine in patients with renal transplants].
    Hrvacević R; Ignjatović Lj; Butorajac J; Vavić N; Drasković-Pavlović B; Dujić A; Marić M
    Vojnosanit Pregl; 2001; 58(3):255-8. PubMed ID: 11548550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: evaluation of efficacy and safety.
    Ju MK; Huh KH; Park KT; Kim SJ; Cho BH; Kim CD; So BJ; Kang CM; Lee S; Joo DJ; Kim YS
    Transplant Proc; 2013 May; 45(4):1481-6. PubMed ID: 23726602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.
    Renders L; Steinbach R; Valerius T; Schöcklmann HO; Kunzendorf U
    Kidney Blood Press Res; 2004; 27(3):181-5. PubMed ID: 15256815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
    Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure caused by hyperuremic acidemia in ABO-incompatible kidney transplant maintained with cyclosporine and high-dose mizoribine: a case report.
    Akioka K; Masuda K; Harada S; Nakamura T; Okugawa K; Nakano K; Osaka Y; Tsuchiya K; Sako H
    Transplant Proc; 2013 Sep; 45(7):2815-8. PubMed ID: 24034056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients--4-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Okajima H; Okamoto M
    Transplant Proc; 2013 May; 45(4):1472-5. PubMed ID: 23726600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.